Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I did ask investor relations why the ASHM is in Chicago

I did ask investor relations why the ASHM is in Chicago

posted on Dec 10, 2009 11:32PM

On Dec. 4, I receveived the following reply which I already posted on this board.

The shareholder meeting was moved to Chicago for the reason stated in our recent news release. It is more centrally located and provides a major transportation hub. Although several shareholders have objected to this change in venue, the great majority has positively responded and has indicated this presents for them an opportunity to attend.

Share
New Message
Please login to post a reply